# Impact of Nociception Level (NOL)-Guided Remifentanil Infusion on Intraoperative Arterial Pressure and Vasopressor Necessity

> **NCT04963036** · NA · UNKNOWN · sponsor: **Centre Hospitalier Universitaire Saint Pierre** · enrollment: 50 (estimated)

## Conditions studied

- Head and Neck Surgery
- Maxillofacial Surgery

## Interventions

- **OTHER:** Entropy and NOL-Guided Goal Directed Anesthesia
- **OTHER:** Standard of Care Group (Entropy and blinded NOL)

## Key facts

- **NCT ID:** NCT04963036
- **Lead sponsor:** Centre Hospitalier Universitaire Saint Pierre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-28
- **Primary completion:** 2022-06
- **Final completion:** 2022-06
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04963036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04963036, "Impact of Nociception Level (NOL)-Guided Remifentanil Infusion on Intraoperative Arterial Pressure and Vasopressor Necessity". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04963036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*